Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Capsule commentary on Long and Stavert, portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysis.

Kahn JG, Marseille EA.

J Gen Intern Med. 2013 Oct;28(10):1350. doi: 10.1007/s11606-013-2519-9. No abstract available.

2.

Portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysis.

Long EF, Stavert RR.

J Gen Intern Med. 2013 Oct;28(10):1294-301. doi: 10.1007/s11606-013-2417-1. Epub 2013 Apr 16.

3.
4.

Using cost-effectiveness league tables to compare interventions to prevent sexual transmission of HIV.

Pinkerton SD, Johnson-Masotti AP, Holtgrave DR, Farnham PG.

AIDS. 2001 May 4;15(7):917-28.

PMID:
11399964
5.

HIV prevention and treatment in South Africa: affordable and desirable.

Decosas J.

Lancet. 2003 Apr 5;361(9364):1146-7. No abstract available. Erratum in: Lancet. 2003 Jul 5;362(9377):84.

PMID:
12686033
6.
7.

HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries.

Marseille E, Dandona L, Marshall N, Gaist P, Bautista-Arredondo S, Rollins B, Bertozzi SM, Coovadia J, Saba J, Lioznov D, Du Plessis JA, Krupitsky E, Stanley N, Over M, Peryshkina A, Kumar SG, Muyingo S, Pitter C, Lundberg M, Kahn JG.

BMC Health Serv Res. 2007 Jul 12;7:108.

8.
9.
10.

Vaginal microbicides save money: a model of cost-effectiveness in South Africa and the USA.

Verguet S, Walsh JA.

Sex Transm Infect. 2010 Jun;86(3):212-6. doi: 10.1136/sti.2009.037176.

PMID:
20522634
11.

Paying to waste lives: the affordability of reducing mother-to-child transmission of HIV in South Africa.

Skordis J, Nattrass N.

J Health Econ. 2002 May;21(3):405-21. Erratum in: J Health Econ 2002 Sep;21(5):927.

PMID:
12022266
12.

Financing HIV/AIDS programs in sub-Saharan Africa.

Haacker M.

Health Aff (Millwood). 2009 Nov-Dec;28(6):1606-16. doi: 10.1377/hlthaff.28.6.1606.

PMID:
19887402
13.

Costs of measures to control tuberculosis/HIV in public primary care facilities in Cape Town, South Africa.

Hausler HP, Sinanovic E, Kumaranayake L, Naidoo P, Schoeman H, Karpakis B, Godfrey-Faussett P.

Bull World Health Organ. 2006 Jul;84(7):528-36.

14.

Costs of eliminating HIV in South Africa have been underestimated.

Wagner B, Blower S.

Lancet. 2010 Sep 18;376(9745):953-4. doi: 10.1016/S0140-6736(10)61442-0. No abstract available.

PMID:
20851250
15.

The cost-effectiveness of herpes simplex virus-2 suppressive therapy with daily aciclovir for delaying HIV disease progression among HIV-1-infected women in South Africa.

Vickerman P, Devine A, Foss AM, Delany-Moretlwe S, Mayaud P, Meyer-Rath G.

Sex Transm Dis. 2011 May;38(5):401-9. doi: 10.1097/OLQ.0b013e31820b8bc8.

PMID:
21317689
16.

Provision of bednets and water filters to delay HIV-1 progression: cost-effectiveness analysis of a Kenyan multisite study.

Kern E, Verguet S, Yuhas K, Odhiambo FH, Kahn JG, Walson J.

Trop Med Int Health. 2013 Aug;18(8):916-24. doi: 10.1111/tmi.12127. Epub 2013 May 10.

17.

Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence.

Creese A, Floyd K, Alban A, Guinness L.

Lancet. 2002 May 11;359(9318):1635-43. Review. Erratum in: Lancet 2002 Sep 14;360(9336):880.

PMID:
12020523
18.

Cost-effectiveness of a behavioral intervention for seropositive youth.

Lee MB, Leibowitz A, Rotheram-Borus MJ.

AIDS Educ Prev. 2005 Apr;17(2):105-18.

PMID:
15899749
19.

The real price of fighting AIDS.

Ramo JC.

Time. 2001 Jul 9;158(1):35. No abstract available.

PMID:
11460448
20.

Male circumcision at different ages in Rwanda: a cost-effectiveness study.

Binagwaho A, Pegurri E, Muita J, Bertozzi S.

PLoS Med. 2010 Jan 19;7(1):e1000211. doi: 10.1371/journal.pmed.1000211.

Supplemental Content

Support Center